Cannabis Science Inc. Reports Treatments for H1N1 Swine Flu
Posted: Tue 28th Apr 2009 06:49 am
Cannabis Science Inc. Reports Treatments for H1N1 Swine Flu and H5N1 Bird Flu
Cannabis Science Inc., an emerging pharmaceutical cannabis company, reported today on the current state of development of its whole-cannabis lozenge in response to Homeland Security Administration Secretary Janet Napolitano's declaration of a public health emergency to deal with the emerging Swine Flu pandemic. The Company's non-toxic lozenge has properties that could alleviate many of the symptoms and harmful effects of the H5N1 bird flu and H1N1 swine flu viruses, and has offered its assistance to HSA today in a letter to Secretary Napolitano. The Company has offered to produce up to 1 million doses of its whole-cannabis lozenge, and provide them to HSA for distribution at cost.
Cannabis Science Inc., President & CEO, Steven W. Kubby said, "We have the science and preliminary anecdotal results confirming the anti-inflammatory properties of our new lozenges and indicating they may present an effective and non-toxic treatment for minimizing the symptoms and harm from influenza infections. Our lozenges appear to down-regulate the body's excessive inflammatory response to the influenza virus, which could reduce the deadly consequences of an infection into something that is more like a common cold. Because of my cancer and diminished auto-immune functions, even common influenza is a deadly threat, and I've had incredible symptomatic relief with the lozenge."
Dr. Robert J. Melamede, Director and Chief Science Officer, stated, "The influenza virus has a unique genetic make up that, in combination with its replicative machinery, has an extraordinary capacity to mutate. As a result, the high lethality of some strains can be attributed to the resulting adult respiratory distress syndrome (ARDS). ARDS is caused by an excessive immune inflammatory response driven by Tumor Necrosis Factor (TNF) that leads to the death of respiratory epithelial cells and resulting organ failure. Endocannabinoids are nature's way of controlling TNF activity. Existing peer reviewed publications have shown that phytocannabinoids can prevent this cell death by mimicking the endocannabinoids that nature has selected to prevent excessive inflammatory immune responses."
Dr. Melamede, who is also a researcher and past Chairman of the Biology Department at the University of Colorado Springs (UCCS), cautioned, "Smoked marijuana will not effectively prevent the excessive inflammatory response, despite delivering the beneficial pharmacological agents, due to the irritating, pro-inflammatory nature of smoke. In fact, I believe it will make things worse and should be avoided by infected individuals."
Source & remainder of article
Cannabis Science Inc., an emerging pharmaceutical cannabis company, reported today on the current state of development of its whole-cannabis lozenge in response to Homeland Security Administration Secretary Janet Napolitano's declaration of a public health emergency to deal with the emerging Swine Flu pandemic. The Company's non-toxic lozenge has properties that could alleviate many of the symptoms and harmful effects of the H5N1 bird flu and H1N1 swine flu viruses, and has offered its assistance to HSA today in a letter to Secretary Napolitano. The Company has offered to produce up to 1 million doses of its whole-cannabis lozenge, and provide them to HSA for distribution at cost.
Cannabis Science Inc., President & CEO, Steven W. Kubby said, "We have the science and preliminary anecdotal results confirming the anti-inflammatory properties of our new lozenges and indicating they may present an effective and non-toxic treatment for minimizing the symptoms and harm from influenza infections. Our lozenges appear to down-regulate the body's excessive inflammatory response to the influenza virus, which could reduce the deadly consequences of an infection into something that is more like a common cold. Because of my cancer and diminished auto-immune functions, even common influenza is a deadly threat, and I've had incredible symptomatic relief with the lozenge."
Dr. Robert J. Melamede, Director and Chief Science Officer, stated, "The influenza virus has a unique genetic make up that, in combination with its replicative machinery, has an extraordinary capacity to mutate. As a result, the high lethality of some strains can be attributed to the resulting adult respiratory distress syndrome (ARDS). ARDS is caused by an excessive immune inflammatory response driven by Tumor Necrosis Factor (TNF) that leads to the death of respiratory epithelial cells and resulting organ failure. Endocannabinoids are nature's way of controlling TNF activity. Existing peer reviewed publications have shown that phytocannabinoids can prevent this cell death by mimicking the endocannabinoids that nature has selected to prevent excessive inflammatory immune responses."
Dr. Melamede, who is also a researcher and past Chairman of the Biology Department at the University of Colorado Springs (UCCS), cautioned, "Smoked marijuana will not effectively prevent the excessive inflammatory response, despite delivering the beneficial pharmacological agents, due to the irritating, pro-inflammatory nature of smoke. In fact, I believe it will make things worse and should be avoided by infected individuals."
Source & remainder of article
(which isnt much anyway...)